Drugs & Targets Quest Diagnostics launches pharmacogenomics lab testing September 19, 2025Vol.51 No.34
Guest Editorial Reflections of a cancer scientistMaintaining the pace of novel technologies will lead to more efficient and less toxic medicines September 12, 2025Vol.51 No.33By Ze’ev Ronai
Cancer Policy After stormy Senate hearing, Trump offers tepid support for RFK Jr. while Kennedy family members call for his ouster September 12, 2025Vol.51 No.33By Claire Marie Porter
Cancer Policy Trump administration releases MAHA report on children’s health September 12, 2025Vol.51 No.33By Claire Marie Porter
Cancer Policy Vinay Prasad regains role as FDA chief medical and scientific officer September 12, 2025Vol.51 No.33By Claire Marie Porter
Cancer Policy FDA advances rare disease drug development with new evidence principles September 12, 2025Vol.51 No.33By Jacquelyn Cobb
Cancer Policy As House committee gives NIH a small raise, cancer groups hope to maintain bipartisan support September 12, 2025Vol.51 No.33By Claire Marie Porter
In Brief Mark Foundation for Cancer Research, Samuel Waxman Cancer Research Foundation establish Aging & Cancer Institute September 12, 2025Vol.51 No.33
In Brief Anirban Maitra, Manuel Hidalgo, join NYU Langone new GI cancer center as co-directors September 12, 2025Vol.51 No.33
